drugset / Trial / NCT00584818
Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease
NaSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to determine the dose of PB127 for detection and/or exclusion of coronary artery disease when used with cardiac ultrasound. This study also evaluates the safety of PB127.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PB127 | Diagnostic / imaging agent | 0.009 mg/kg | Intravenous |
| Subject | PB127 | Diagnostic / imaging agent | 0.062 mg/kg | Intravenous |
| Subject | PB127 | Diagnostic / imaging agent | 0.204 mg/kg | Intravenous |